Home > Insider Trading > Filing (0001567619-20-004734)

Filing Details

Accession Number:: 0001567619-20-004734
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-02-24 17:51:43
Reporting Period:: 2020-02-19

Accepted Time:: 2020-02-24 17:51:43
Original Submission Date:: 2020-02-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184149	W Jonathan Ayers	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-02-19	1,021	$288.00	847,983	No	4	S	Direct
Common Stock	Disposition	2020-02-19	758	$288.50	847,225	No	4	S	Direct
Common Stock	Disposition	2020-02-19	900	$289.52	846,325	No	4	S	Direct
Common Stock	Disposition	2020-02-19	100	$290.35	846,225	No	4	S	Direct
Common Stock	Disposition	2020-02-19	100	$291.46	846,125	No	4	S	Direct
Common Stock	Disposition	2020-02-19	3,000	$293.04	843,125	No	4	S	Direct
Common Stock	Disposition	2020-02-19	8,104	$293.94	835,021	No	4	S	Direct
Common Stock	Disposition	2020-02-19	7,042	$295.02	827,979	No	4	S	Direct
Common Stock	Disposition	2020-02-19	634	$288.43	827,345	No	4	S	Direct
Common Stock	Disposition	2020-02-19	805	$289.48	826,540	No	4	S	Direct
Common Stock	Disposition	2020-02-19	100	$290.16	826,440	No	4	S	Direct
Common Stock	Disposition	2020-02-19	1,406	$292.71	825,034	No	4	S	Direct
Common Stock	Disposition	2020-02-19	6,846	$293.78	818,188	No	4	S	Direct
Common Stock	Disposition	2020-02-19	7,827	$294.84	810,361	No	4	S	Direct
Common Stock	Disposition	2020-02-19	500	$295.21	809,861	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	138,000	Indirect	by Ayers Family Trust

Footnotes

Represents the weighted average price of the shares sold ranging from a low of $288.00 to a high of $289.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $289.04 to a high of $290.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $292.48 to a high of $293.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $293.50 to a high of 294.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $294.56 to a high of $295.44 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $288.00 to a high of $288.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $289.02 to a high of $289.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $292.00 to a high of $292.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $293.06 to a high of $294.035 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $294.07 to a high of $295.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $295.07 to a high of $295.64 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
The Form 4 has been amended to correct the amount of securities beneficially owned following the reported transactions.